Anna Jamroz-Wiśniewska Selected Research

Cholecalciferol (Vitamin D3)

12/2011

Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Jamroz-Wiśniewska Research Topics

Disease

9	Hypertension (High Blood Pressure) 12/2008 - 01/2004
7	Obesity 01/2014 - 01/2004
4	Multiple Sclerosis 05/2022 - 01/2020
4	Insulin Resistance 01/2018 - 03/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2016 - 03/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2012 - 03/2008
1	Pain (Aches) 06/2022
1	COVID-19 05/2022
1	Retinal Artery Occlusion 03/2022
1	Sclerosis 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2021
1	Neuroinflammatory Diseases 07/2021
1	Relapsing-Remitting Multiple Sclerosis 04/2021
1	Hyperhomocysteinemia 01/2020
1	Disease Progression 01/2020
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Weight Loss (Weight Reduction) 05/2019
1	Inflammation (Inflammations) 01/2018
1	Diabetes Mellitus 01/2018
1	Diabetes Complications 10/2016
1	HIV Infections (HIV Infection) 01/2014
1	Spastic Paraparesis 01/2014
1	Substance-Related Disorders (Drug Abuse) 01/2014
1	Reperfusion Injury 07/2012
1	Hyperglycemia 07/2010
1	Hyperinsulinism (Hyperinsulinemia) 10/2009
1	Rhabdomyolysis 09/2009
1	Muscular Diseases (Myopathy) 09/2009
1	Vascular System Injuries 03/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2008
1	Glucose Intolerance 03/2008
1	Hyperlipidemias (Hyperlipidemia) 03/2008
1	Essential Hypertension 03/2008
1	Neointima 03/2008
1	Neoplasms (Cancer) 12/2007
1	Fatty Liver 12/2007
1	Atherosclerosis 06/2005
1	Body Weight (Weight, Body) 03/2004

Drug/Important Bio-Agent (IBA)

14	LeptinIBA 01/2014 - 01/2004
4	SodiumIBA 07/2021 - 03/2004
4	AntioxidantsIBA 01/2020 - 03/2005
3	endothelium-dependent hyperpolarization factor (EDHF)IBA 01/2014 - 05/2006
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2011 - 12/2007
3	Adenosine Triphosphatases (ATPase)IBA 04/2008 - 01/2004
3	Hormones (Hormone)IBA 03/2008 - 06/2005
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	EnzymesIBA 05/2019 - 12/2008
2	AdipokinesIBA 01/2018 - 03/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2016
2	Insulin (Novolin)FDA Link 12/2016 - 12/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012 - 09/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009 - 03/2008
1	mesoglycanIBA 06/2022
1	VaccinesIBA 05/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2022
1	COVID-19 VaccinesIBA 01/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2021
1	Natalizumab (Tysabri)FDA Link 04/2021
1	HomocysteineIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Exenatide (Byetta)FDA Link 05/2019
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 10/2016
1	Nonesterified Fatty Acids (NEFA)IBA 12/2011
1	Atorvastatin (Lipitor)FDA Link 12/2011
1	Cholecalciferol (Vitamin D3)FDA Link 12/2011
1	Glycerol (Glycerine)FDA LinkGeneric 12/2011
1	Vitamin D FDA LinkGeneric 12/2011
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2011
1	phenyl acetateIBA 07/2010
1	Paraoxon (E600)IBA 07/2010
1	FructoseIBA 10/2009
1	Serine (L-Serine)FDA Link 10/2009
1	Drinking WaterIBA 10/2009
1	Glutathione (Reduced Glutathione)IBA 12/2008
1	ErbB Receptors (EGF Receptor)IBA 04/2008
1	Epidermal Growth Factor (EGF)IBA 04/2008
1	AdiponectinIBA 03/2008
1	ResistinIBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2008
1	Lipoproteins (Lipoprotein)IBA 03/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2008
1	Superoxides (Superoxide)IBA 02/2008
1	Triglycerides (Triacylglycerol)IBA 12/2007
1	Transcription Factors (Transcription Factor)IBA 12/2007
1	ReninIBA 12/2007
1	Amyloid (Amyloid Fibrils)IBA 12/2007
1	Sterol Regulatory Element Binding Protein 1IBA 12/2007
1	sodium-translocating ATPase (ATPase, sodium)IBA 01/2004
1	Ouabain (G Strophanthin)IBA 01/2004

Therapy/Procedure

5	Therapeutics 05/2022 - 04/2008
1	Blood Transfusion (Blood Transfusions) 01/2014